Work

The FLT3 inhibitor midostaurin selectively resensitizes ABCB1-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic agents

Year: 2019

Type: article

Source: Cancer Letters

DOI: 10.1016/j.canlet.2019.01.001

Authors: Sung-Han Hsiao, Sabrina Lusvarghi, Yang-Hui Huang, Suresh V. Ambudkar, Sheng-Chieh Hsu, Chung-Pu Wu

Institutions: Chang Gung University, National Institutes of Health, National Cancer Institute, Center for Cancer Research, Chang Gung Memorial Hospital, Linkou Chang Gung Memorial Hospital

Language: English

Topic: Drug Transport and Resistance Mechanisms

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Institutes of Health

Award: G9000273969

OpenAlex ID: W2909486671

FWCI: 2.357

Cites: 83

Cited by: 40

Related to: 10